See Accompanying Notes to Condensed Consolidated Financial Statements.
See Accompanying Notes to Condensed Consolidated Financial Statements.
See Accompanying Notes to Condensed Consolidated Financial Statements.
See Accompanying Notes to Condensed Consolidated Financial Statements.
The LGL Group, Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial reporting and the instructions to Form 10-Q. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with the information included in The LGL Group, Inc. (the “Company”, “LGL Group”, “LGL”, “we”, “our” or “us”) Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (the “SEC”) on March 28, 2022.
Spin-Off of M-tron Industries, Inc.
On August 3, 2022, LGL announced that its Board of Directors approved the previously announced separation of the M-tron Industries, Inc. (“MtronPTI”) business into an independent, publicly traded company (the "Separation" or “Spin-Off”). Prior to the Separation, LGL Group operated its electronic instruments business segment through its wholly-owned subsidiary, Precise Time and Frequency (“PTF”) and its electronic components business segment through MtronPTI.
On October 7, 2022 the Separation of the MtronPTI business was completed and MtronPTI became an independent, publicly-traded company trading on the NYSE American under the stock symbol "MPTI.
The Separation was achieved through LGL’s distribution (the “Distribution”) of 100% of the shares of MtronPTI's common stock to holders of LGL's common stock as of the close of business on the record date of September 30, 2022. LGL's stockholders of record received one-half share of MtronPTI's common stock for every share of LGL's common stock. In connection with the Separation, MtronPTI wrote off $4,439,000 of intercompany receivables due from LGL, which brought intercompany balances to zero. LGL retained no ownership interest in the MtronPTI business following the Separation. Spin-Off costs were $232,000 and $575,000 for the three and nine months ended September 30, 2022, respectively. Beginning in the fourth quarter of 2022, the historical financial results of the MtronPTI business for periods prior to the distribution date along with the related direct costs of the Spin-Off will be reflected in the Company’s consolidated financial statements as discontinued operations.
B. |
Summary of Significant Accounting Policies |
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries except its sole variable interest entity (“VIE”), LGL Systems Acquisition Holding Company, LLC (the “Sponsor”). Intercompany transactions and accounts have been eliminated in consolidation. The VIE served as the Sponsor to a special purpose acquisition company, LGL Systems Acquisition Corp. (the “SPAC” or “DFNS”). The SPAC completed a merger with its target company, IronNet Cybersecurity, Inc., on August 26, 2021 and changed its name to IronNet, Inc. (“IronNet” or “IRNT”) (the “IronNet Business Combination”). IronNet is a publicly-traded company on the NYSE American (“NYSE”) under the ticker symbol “IRNT.”
VIE: Our sole interest in a VIE, the Sponsor, was accounted for under the equity method of accounting and not consolidated. Determining whether to consolidate a VIE requires judgement in assessing whether an entity is a VIE and if we are the entity’s primary beneficiary. If we are the primary beneficiary of a VIE, we are required to consolidate the entity. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation included identification of significant activities and an assessment of our ability to direct those activities, based on operating and other legal agreements as well as governance provisions. As a result of our review, we concluded that we were not the primary beneficiary of the VIE and that consolidation was not warranted.
The Sponsor is managed by LGL Systems Nevada Management Partners LLC (“Nevada GP”), an affiliated entity deemed to be under the significant influence of Marc Gabelli, the Company’s non-executive Chairman of the Board, who is also a greater than 10% stockholder of the Company. The Company has determined that it is not the primary beneficiary of the Sponsor, as Nevada GP has the power to direct the activities of the Sponsor that most significantly impact the Sponsor’s economic performance through an operating agreement. The Company, therefore, accounts for the Sponsor under the equity method of accounting.
5
Equity-Method Investments: When the Company does not have a controlling financial interest in an entity but can exert significant influence over the entity’s operating and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under GAAP. Significant influence generally exists when the Company owns 20% to 50% of the entity’s common stock or in-substance common stock. In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of earnings or losses of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Following the Sponsor’s September 2021 distribution of IRNT securities to the Company, as more fully described in Note C – Equity Investment in Unconsolidated Subsidiary, the Company’s remaining investment in the Sponsor is de minimis.
Revenue Recognition
The Company recognizes revenue from the sale of its products in accordance with the criteria in Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which are:
Step 1: Identify the contract(s) with a customer.
Step 2: Identify the performance obligations in the contract.
Step 3: Determine the transaction price.
Step 4: Allocate the transaction price to the performance obligations in the contract.
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
The Company meets these conditions upon the Company’s satisfaction of the performance obligation, usually at the time of shipment to the customer, because control passes to the customer at that time. Our standard terms for customers are net due within 30 days, with a few exceptions, none regularly exceeding 60 days.
The Company’s two product groupings, Frequency Control and Spectrum Control, have identical characteristics for revenue recognition. Both are recognized upon shipment to the customer.
The Company provides disaggregated revenue details by segment in Note L – Segment Information, and geographic markets in Note M – Domestic and Foreign Revenues.
The Company offers a limited right of return and/or authorized price protection provisions in its agreements with certain electronic component distributors who resell the Company's products to original equipment manufacturers or electronic manufacturing services companies. As a result, the Company estimates and records a reserve for future returns and other charges against revenue at the time of shipment consistent with the terms of sale. The reserve is estimated based on historical experience with each respective distributor. These reserves and charges are immaterial as the Company does not have a history of significant price protection adjustments or returns. The Company provides a standard assurance warranty that does not create a performance obligation.
Practical Expedients:
|
- |
The Company applies the practical expedient for shipping and handling as fulfillment costs. |
|
- |
The Company expenses sales commissions as sales and marketing expenses in the period they are incurred. |
Impairment of Long-Lived Assets
Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Long-lived assets are grouped with other assets to the lowest level to which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Management assesses the recoverability of the carrying cost of the assets based on a review of projected undiscounted cash flows. If an asset is held for sale, management reviews its estimated fair value less cost to sell. Fair value is determined using pertinent market information, including appraisals or broker's estimates, and/or projected discounted cash flows. In the event an impairment loss is identified, it is recognized based on the amount by which the carrying value exceeds the estimated fair value of the long-lived asset.
We performed an assessment to determine if there were any indicators of impairment as a result of the operating conditions resulting from the coronavirus (“COVID-19”) pandemic at the end of the fiscal quarter ended September 30, 2022. We concluded that, while there were events and circumstances in the macro-environment that did impact us, we did not experience any entity-specific indicators of asset impairment and no triggering events occurred.
Recent Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2016-13, “Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments,” which changes the impairment model for most financial assets. The standard replaces the incurred loss model with the current expected credit loss (“CECL”) model to estimate credit losses for financial assets. The provisions of the standard are effective for the Company on January 1, 2023; early adoption is permitted. The Company does not expect a material impact to its consolidated financial statements upon adopting this standard.
6
C. |
Equity Investment in Unconsolidated Subsidiary |
In November 2019, the Company made its initial investment of $3,350,000 in the Sponsor of the SPAC and subscribed to an additional investment of $2,725,000 in March 2021, which was funded in May 2021. The incremental investment was part of the Sponsor syndication to participate in a private placement in connection with the IronNet Business Combination. As previously discussed, the SPAC completed a merger with its target company on August 26, 2021 and the combined company began trading its common stock on the NYSE under the symbol “IRNT.”
On September 14, 2021, as a result of its Sponsor investment, the Company received 1,572,529 shares of IRNT common stock and 2,065,000 IRNT warrants exchangeable into shares of IRNT common stock. On October 1, 2021, the Company exercised its 2,065,000 warrants on a cashless basis and received 1,271,406 shares of IRNT common stock. To date, the Company has disposed of 1,555,315 of its 2,843,935 shares of IRNT common stock and derivatives purchased as part of its plan to minimize the economic risk of IRNT share price volatility and received related proceeds of approximately $20,200,000, with 1,288,620 shares of IRNT common stock remaining in our portfolio at September 30, 2022 valued at $887,859. Subsequent to the September 14, 2021 Sponsor distribution, the Company’s IRNT common stock and warrants were classified as marketable securities under ASC 321, Investments – Equity Securities (“ASC 321”), with any change in fair value reported as an unrealized gain or loss. See Note D - Marketable Securities. Subsequent to the September 14, 2021 Sponsor distribution, LGL’s interest in the Sponsor is immaterial.
D. Marketable Securities
The Company accounts for equity securities under ASC 321. Such securities are reported at fair value on the consolidated balance sheets, and the related unrealized gains and losses are reported in the consolidated statements of cash flows as non-cash adjustments to income. Any realized and unrealized gains or losses on investment securities are reported in the consolidated statements of operations as investment income or (loss). Investment loss was $2,121,000 and $18,867,000 for the three months ended September 30, 2022 and 2021, respectively. Investment loss was $4,449,000 and $18,665,000 for the nine months ended September 30, 2022 and 2021, respectively. During the nine months ended September 30, 2022, the Company recorded realized gains on marketable securities of $112,000 related to a realized gain of $856,000 on the sale of 250,000 IRNT put options, offset by a realized loss of $744,000 for the delivery of 50,000 shares of IRNT common stock against the related derivative position. There were no realized gains or losses for the prior year quarter or year-to-date period.
Details of marketable securities held at September 30, 2022 and December 31, 2021 are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
Cumulative |
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
Fair Value |
|
|
Basis |
|
|
(Loss) Gain |
|
IronNet Securities: |
|
September 30, 2022 |
|
1,288,620 shares of common stock |
|
$ |
888 |
|
|
$ |
27,636 |
|
|
$ |
(26,748 |
) |
Put options |
|
|
26 |
|
|
|
13 |
|
|
|
13 |
|
|
|
|
914 |
|
|
|
27,649 |
|
|
|
(26,735 |
) |
Equity funds and other securities |
|
|
16,156 |
|
|
|
16,808 |
|
|
|
(652 |
) |
|
|
$ |
17,070 |
|
|
$ |
44,457 |
|
|
$ |
(27,387 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
IronNet Securities: |
|
December 31, 2021 |
|
1,338,620 shares of common stock |
|
$ |
5,106 |
|
|
$ |
28,696 |
|
|
$ |
(23,590 |
) |
Put options |
|
|
1,245 |
|
|
|
489 |
|
|
|
756 |
|
|
|
|
6,351 |
|
|
|
29,185 |
|
|
|
(22,834 |
) |
Equity funds and other securities |
|
|
9,816 |
|
|
|
9,808 |
|
|
|
8 |
|
|
|
$ |
16,167 |
|
|
$ |
38,993 |
|
|
$ |
(22,826 |
) |
The shares of IRNT common stock were received by the Company as a result of the previously discussed Sponsor distribution. The fair value of these shares determined at the date of distribution represents the basis of these securities.
At December 31, 2021, the Company held 1,250,000 shares of IRNT common stock that were restricted from sale until early 2022. The fair value of these shares of restricted common stock was determined by applying a discount for lack of marketability to the publicly quoted market price of IRNT common stock at December 31, 2021. During the first quarter of 2022, the sale restrictions were released. The fair value of our IRNT securities at September 30, 2022 was determined based on their publicly quoted market price.
The Company executed derivatives transactions as part of its plan to minimize the economic risk of IRNT share price volatility to its IRNT holdings. The Company held put options, covering shares of IRNT common stock with a May 2022 expiration date, for 300,000 shares of IRNT common stock at December 31, 2021. During the first quarter of 2022, the Company delivered 50,000 shares against its IRNT put options. On May 5, 2022, the Company sold put options held at March 31, 2022 covering 250,000 shares of IRNT
7
common stock for $1,263,000. At September 30, 2022, the Company held put options, covering shares of IRNT common stock with a fourth quarter 2022 expiration date, for 100,500 IRNT shares.
E. |
Related Party Transactions |
Certain balances held and invested in various mutual funds are managed by a related entity (the "Fund Manager"). Marc Gabelli, the Company’s non-executive Chairman of the Board, who is also a greater than 10% stockholder, serves as an executive officer of the Fund Manager. The brokerage and fund transactions in 2022 and 2021 were directed solely at the discretion of the Company’s management. See Note F – Fair Value Measurements for further discussion of the investments in mutual funds that are managed by the Fund Manager.
As of September 30, 2022, the balance with the Fund Manager totaled $21,990,000, including $5,857,000 which is classified within cash and cash equivalents on the accompanying condensed consolidated balance sheets and $16,133,000 which is classified within marketable securities on the accompanying condensed consolidated balance sheets. Amounts invested generated ($168,000) and ($29,000) of investment (loss) income during the three months ended September 30, 2022 and 2021, respectively. Amounts invested generated ($638,000) and $174,000 of investment (loss) income during the nine months ended September 30, 2022 and 2021, respectively. Fund management fees are anticipated to average approximately 0.60% or $133,000 for the nine months ended September 30, 2022 and 0.35% or $54,000 for the nine months ended September 30, 2021 of the asset balances under management on an annual basis, as calculated by management using publicly available information for portfolio management fees.
As of December 31, 2021, the balance with the Fund Manager totaled $15,595,000, including $5,823,000 which is classified within cash and cash equivalents on the accompanying condensed consolidated balance sheets and $9,772,000 which is classified as marketable securities on the accompanying condensed consolidated balance sheets.
Certain members of our board of directors (the “Board”) including Marc Gabelli, John Mega, Timothy Foufas, Manjit Kalha and Michael Ferrantino, and two of our management team, Patrick Huvane and Michael Ferrantino, are members of the Sponsor. Robert LaPenta joined IronNet as a board member upon the IronNet Business Combination and was a member of our Board until his resignation on September 27, 2021. Mr. LaPenta remains a passive member of the Sponsor. All except Mr. Kalha also served in various capacities of the SPAC but have all since resigned from the SPAC upon completion of the IronNet Business Combination on August 26, 2021. Prior to their resignations, John Mega was President of the SPAC, Timothy Foufas was Chief Operating Officer of the SPAC, Robert LaPenta was Co-Chief Executive Officer and Chief Financial Officer of the SPAC, Mr. Gabelli was the Chairman and Co-Chief Executive Officer of the SPAC, Michael Ferrantino was a SPAC board member and Patrick Huvane was a SPAC officer. Mr. Foufas, Mr. Huvane and Mr. Gabelli are managing members of the Sponsor. Mr. Huvane became a managing member of the Sponsor on September 27, 2021.
F. |
Fair Value Measurements |
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value guidance identifies three primary valuation techniques: the market approach, the income approach and the cost approach. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts, such as cash flows or earnings, to a single present amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that currently would be required to replace the service capacity of an asset.
The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to observable inputs such as quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The maximization of observable inputs and the minimization of the use of unobservable inputs are required.
Classification within the fair value hierarchy is based upon the objectivity of the inputs that are significant to the valuation of an asset or liability as of the measurement date. The three levels within the fair value hierarchy are characterized as follows:
Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 - Unobservable inputs for the asset or liability for which there is little, if any, market activity for the asset or liability at the measurement date. Unobservable inputs reflect the Company's own assumptions about what market participants would use to price the asset or liability. These inputs may include internally developed pricing models, discounted cash flow methodologies as well as instruments for which the fair value determination requires significant management judgment.
8
Assets
To estimate the market value of its cash and cash equivalents and marketable securities, the Company obtains current market pricing from quoted market sources or uses pricing for identical securities adjusted for liquidity, when applicable. Assets measured at fair value on a recurring basis are summarized below (in thousands).
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total at September 30,
2022 |
|
Equity Securities |
|
$ |
911 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
911 |
|
Equity Mutual Fund |
|
$ |
— |
|
|
$ |
15,945 |
|
|
$ |
— |
|
|
$ |
15,945 |
|
Commodity Mutual Fund |
|
$ |
— |
|
|
$ |
188 |
|
|
$ |
— |
|
|
$ |
188 |
|
Derivative Contract Asset |
|
$ |
26 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
26 |
|
U.S. Treasury Mutual Funds |
|
$ |
12,942 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
12,942 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total at December 31, 2021 |
|
Equity Securities |
|
$ |
416 |
|
|
$ |
4,734 |
|
|
$ |
— |
|
|
$ |
5,150 |
|
Equity Mutual Fund |
|
$ |
— |
|
|
$ |
9,523 |
|
|
$ |
— |
|
|
$ |
9,523 |
|
Commodity Mutual Fund |
|
$ |
— |
|
|
$ |
249 |
|
|
$ |
— |
|
|
$ |
249 |
|
Derivative Contract Asset |
|
$ |
1,245 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,245 |
|
U.S. Treasury Mutual Funds |
|
$ |
12,889 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
12,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2022 and December 31, 2021, the Company had investments in four mutual funds. The Equity Mutual Fund noted above is invested in the Gabelli ABC Fund and the Commodity Mutual Fund was invested in the Gabelli Gold Fund. The U.S. Treasury Mutual Funds, included in cash and cash equivalents, are invested in the Gabelli US Treasury Money Market Fund and the BlackRock Liquidity Treasury Trust Money Market Fund.
At December 31, 2021, the Company utilized a Level 2 category fair value measurement to value its investment in certain IronNet common stock holdings. Although IronNet common stock has a quoted price in active markets, a portion of the Company’s year-end IRNT holdings had sale restrictions requiring a discount for lack of marketability and classification as a Level 2 asset. The selling restriction on the restricted IRNT shares lapsed in the first quarter of 2022. The fair value of the IRNT shares without restrictions is determined based on the market price and included within the Level 1 category.
G.Inventories
Inventories are valued at the lower of cost or net realizable value using the FIFO (first-in, first-out) method. The Company reduces the value of its inventories to net realizable value when the net realizable value is believed to be less than the cost of the item. The reserve for excess and obsolete inventory as of September 30, 2022 and December 31, 2021 was $1,675,000 and $1,428,000, respectively.
Inventories are comprised of the following (in thousands):
|
|
September 30,
2022 |
|
|
December 31,
2021 |
|
Raw materials |
|
$ |
3,676 |
|
|
$ |
2,314 |
|
Work in process |
|
|
2,724 |
|
|
|
2,196 |
|
Finished goods |
|
|
1,184 |
|
|
|
982 |
|
Total Inventories, net |
|
$ |
7,584 |
|
|
$ |
5,492 |
|
H. |
Stock-Based Compensation |
Under the Company’s 2021 Incentive Plan, and the prior 2011 Incentive Plan, as amended, restricted stock and stock options have been awarded to certain employees as stock-based compensation. Compensation expense is based on the grant-date fair value and recognized over the requisite service period.
In April 2022, 30,000 restricted shares were issued with a grant date fair value of $10.46 per share, 15,000 restricted shares vested, and 4,786 of the vested shares were withheld to pay taxes. Stock-based compensation expense was $80,000 and $383,000 for the three and nine months ended September 30, 2022, respectively and $19,000 and $116,000 for the three and nine months ended September 30, 2021, respectively. During the third quarter of 2022, there were 15,000 options exercised at a strike price of $12.72 for aggregate proceeds of $191,000. As of September 30, 2022 there was approximately $395,000 of total unrecognized compensation expense related to unvested stock-based compensation arrangements, primarily related to restricted stock awards. This cost will be recognized over the weighted average remaining service period of these awards, which is 1.8 years for restricted stock and 0.1 years for stock
9
options. As a result of the cancellation of awards on October 7, 2022, the Company expects to record $5,000 of stock compensation expense related to these outstanding grants subsequent to September 30, 2022. See Note O – Subsequent Events for further detail.
The Company computes earnings per share in accordance with ASC 260, Earnings Per Share. Basic earnings per share is computed by dividing net earnings by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share adjusts basic earnings per share for the effects of warrants, restricted stock, stock options and other potentially dilutive financial instruments, only in the periods in which the effects are dilutive.
For both the three and nine months ended September 30, 2022 and 2021, there were warrants to purchase 1,051,664 shares of common stock and options to purchase 25,000 shares of common stock excluded from the diluted earnings per share computation because the impact of the assumed exercise of such warrants and stock options would have been anti-dilutive.
The following table reconciles basic weighted average shares outstanding to diluted weighted average shares outstanding for the three and nine months ended September 30, 2022 and 2021:
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Weighted average shares outstanding - basic |
|
|
5,346,043 |
|
|
|
5,273,786 |
|
|
|
5,334,774 |
|
|
|
5,273,263 |
|
Effect of diluted securities |
|
|
— |
|
|
|
52,029 |
|
|
|
— |
|
|
|
61,271 |
|
Weighted average shares outstanding - diluted |
|
|
5,346,043 |
|
|
|
5,325,815 |
|
|
|
5,334,774 |
|
|
|
5,334,534 |
|
The Company’s quarterly provision for income taxes is measured using an annual effective tax rate, adjusted for discrete items within the period presented. To determine the annual effective tax rate, the Company estimates both the total income (loss) before income taxes for the full year and the jurisdictions in which that income (loss) is subject to tax. The actual effective tax rate for the full year may differ from these estimates if income (loss) before income taxes is greater than or less than what was estimated or if the allocation of income (loss) to jurisdictions in which it is taxed is different from the estimated allocations.
The effective tax rate for the nine months ended September 30, 2022 and September 30, 2021 was 22.1% and 22.2%, respectively. The effective tax rate for the three months ended September 30, 2022 and September 30, 2021 was 25.7% and 22.2%, respectively. Differences between the Company’s effective income tax rate and the U.S. federal statutory rate are primarily the impact of research and development credits, the mix of earnings between jurisdictions, and state taxes.
K. |
Revolving Credit Agreement |
On June 15, 2022, M-Tron Industries, Inc. and Piezo Technology, Inc. (collectively, the “Borrowers”), both operating subsidiaries of The LGL Group, Inc. (the “Company”), entered into a loan agreement for a revolving line of credit with Fifth Third Bank, National Association, an unaffiliated entity, as the lender (“Lender”), for up to $5,000,000 (the “Loan Agreement”), such amount to be used for working capital and general operations. The Loan Agreement is evidenced by a promissory note dated June 15, 2022 that matures on June 15, 2025 (the “Note”), and two corresponding security agreements (the “Security Agreements”). The Note bears interest at the Secured Overnight Financing Rate (SOFR) one-month rate plus 2.25%, with a SOFR floor of 0.0%. Accrued interest-only payments are due on a monthly basis until the maturity date. The Borrowers may prepay all or any portion of the loans under the Loan Agreement at any time, without fee, premium or penalty.
The Loan Agreement contains various affirmative and negative covenants that are customary for lines of credit and transactions of this type, including limitations on the incurrence of debt and liabilities by the Borrowers, as well as financial reporting requirements. The Loan Agreement also imposes certain financial covenants based on the following criteria, which are specifically defined in the Loan Agreement: (a) Minimum Fixed Charge Coverage Ratio; (b) Minimum Current Ratio; and (c) Minimum Tangible Net Worth. At September 30, 2022, the Company had no borrowings outstanding under its revolving line of credit with Fifth Third Bank.
10
Prior to the Spin-Off and as of September 30, 2022, the Company has two reportable business segments; electronic components (MtronPTI), and electronic instruments (PTF). The electronic components segment is focused on the design, manufacture and marketing of highly-engineered, high reliability frequency and spectrum control products. These electronic components ensure reliability and security in aerospace and defense communications, low noise and base accuracy for laboratory instruments, and synchronous data transfers throughout the wireless and Internet infrastructure. The electronic instruments segment is focused on the design and manufacture of high performance Frequency and Time Reference Standards that form the basis for timing and synchronization in various applications.
Business segment information follows (in thousands):
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Electronic components |
|
$ |
8,417 |
|
|
$ |
7,173 |
|
|
$ |
23,172 |
|
|
$ |
19,834 |
|
Electronic instruments |
|
|
344 |
|
|
|
328 |
|
|
|
1,131 |
|
|
|
1,085 |
|
Total consolidated revenues |
|
$ |
8,761 |
|
|
$ |
7,501 |
|
|
$ |
24,303 |
|
|
$ |
20,919 |
|
Operating Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Electronic components |
|
$ |
756 |
|
|
$ |
854 |
|
|
$ |
2,521 |
|
|
$ |
2,037 |
|
Electronic instruments |
|
|
(39 |
) |
|
|
32 |
|
|
|
(53 |
) |
|
|
150 |
|
Unallocated corporate expense |
|
|
(596 |
) |
|
|
(1,632 |
) |
|
|
(2,002 |
) |
|
|
(2,377 |
) |
Total operating income (loss) |
|
|
121 |
|
|
|
(746 |
) |
|
|
466 |
|
|
|
(190 |
) |
Interest income (expense), net |
|
|
51 |
|
|
|
(3 |
) |
|
|
51 |
|
|
|
(9 |
) |
Gain on equity investment in unconsolidated subsidiary |
|
|
— |
|
|
|
60,205 |
|
|
|
— |
|
|
|
59,453 |
|
Investment loss |
|
|
(2,121 |
) |
|
|
(18,867 |
) |
|
|
(4,449 |
) |
|
|
(18,665 |
) |
Other (expense) income, net |
|
|
(13 |
) |
|
|
240 |
|
|
|
(37 |
) |
|
|
280 |
|
Total other (expense) income, net |
|
|
(2,083 |
) |
|
|
41,575 |
|
|
|
(4,435 |
) |
|
|
41,059 |
|
(Loss) Income Before Income Taxes |
|
$ |
(1,962 |
) |
|
$ |
40,829 |
|
|
$ |
(3,969 |
) |
|
$ |
40,869 |
|
Operating income is equal to revenues less cost of sales and operating expenses (engineering, selling and administrative expenses).
M. |
Domestic and Foreign Revenues |
Significant foreign revenues from operations (10% or more of foreign sales) follows (in thousands):
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Malaysia |
|
$ |
1,332 |
|
|
$ |
832 |
|
|
$ |
3,856 |
|
|
$ |
1,874 |
|
Hong Kong |
|
|
103 |
|
|
|
140 |
|
|
|
479 |
|
|
|
495 |
|
Germany |
|
|
106 |
|
|
|
127 |
|
|
|
348 |
|
|
|
413 |
|
Hungary |
|
|
236 |
|
|
|
1 |
|
|
|
247 |
|
|
|
7 |
|
All other foreign countries |
|
|
499 |
|
|
|
403 |
|
|
|
1,673 |
|
|
|
1,459 |
|
Total foreign revenues |
|
$ |
2,276 |
|
|
$ |
1,503 |
|
|
$ |
6,603 |
|
|
$ |
4,248 |
|
Total domestic revenue |
|
$ |
6,485 |
|
|
$ |
5,998 |
|
|
$ |
17,700 |
|
|
$ |
16,671 |
|
The Company allocates its foreign revenue based on the customer's ship-to location.
In the ordinary course of business, the Company and its subsidiaries may become defendants in certain product liability, patent infringement, worker claims and other litigation. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable.
11
O.Subsequent Events
M-tron Industries, Inc. Separation
On October 7, 2022, the Separation of MtronPTI was completed through LGL’s distribution of 100% of the shares of MtronPTI's common stock to holders of LGL's common stock as of the close of business on the record date of September 30, 2022. As a result of the Distribution, LGL's stockholders of record received one-half share of MtronPTI's common stock for every share of LGL's common stock. On October 7, 2022, MtronPTI became an independent, public company trading on the NYSE American under the stock symbol "MPTI". LGL retained no ownership interest in MtronPTI as of the completion of the Separation.
In connection with the Separation, MtronPTI wrote off $4,439,000 of intercompany receivables due from LGL, which brought intercompany balances to zero, and left MtronPTI with a cash balance of approximately $1,000,000 as of the date of the Separation.
The Company canceled 52,533 restricted LGL shares and 10,000 options that had been issued to MtronPTI management, effective on October 7, 2022.
Changes in Officers and Directors
On October 7, 2022, John S. Mega and Bel Lazar resigned from the LGL Board to join MtronPTI as directors, and James W. Tivy resigned as Chief Financial Officer of LGL to join MtronPTI as its Chief Financial Officer. In addition, effective as of 12:01 a.m. Eastern Time on October 7, 2022, Marc J. Gabelli was appointed to serve as the Chief Executive Officer of LGL, and James W. Tivy was appointed to serve as the Chief Accounting Officer of LGL. Ivan Arteaga, who currently serves on the Board as a director of LGL, was appointed to serve as the Chief Financial Officer of LGL.
Adjustment of Warrant Price and Target Price for Acceleration
On October 19, 2022, LGL issued a press release (the "Press Release") announcing the adjustment to the terms of exercise for its warrants, as a result of its M-tron Industries, Inc. Spin-Off.
LGL has approximately 5.25 million “European Style” warrants outstanding, exercisable at a 5 for 1 ratio into LGL shares only at the earlier of (i) the expiration of the warrant term, which is November 16, 2025, or (ii) subject to a date acceleration if triggered only after the average volume weighted average price (“VWAP”) of LGL common stock for 30 consecutive trading days is greater than or equal to the acceleration trigger price.
The warrants are publicly listed on the NYSE American under the symbol LGL.WS.
The distribution of MtronPTI shares is a qualifying dilutive event that requires an adjustment, with the exercise price of the warrants and the trigger price for the potential acceleration of the exercise date for its warrants to be adjusted using the calculation provided within the warrant agreement.
Effective October 18, 2022, the warrant exercise price, originally set at $12.50, was adjusted to $4.75, and the target trigger price for potential acceleration of the exercise date, originally set at $17.50, was adjusted to $6.65.
12